Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study

2006 ◽  
Vol 1 (1) ◽  
pp. 13-25
Author(s):  
Sibel Tekin ◽  
Roger Lane
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease

1998 ◽  
Vol 13 (5) ◽  
pp. 782-787 ◽  
Author(s):  
Richard B. Dewey ◽  
Demetrius M. Maraganore ◽  
J. Eric Ahlskog ◽  
Joseph Y. Matsumoto
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Rescue Agent

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

2010 ◽  
Vol 25 (11) ◽  
pp. 1670-1674 ◽  
Author(s):  
Barry J. Snow ◽  
Fiona L. Rolfe ◽  
Michelle M. Lockhart ◽  
Christopher M. Frampton ◽  
John D. O'Sullivan ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Disease Modifying Therapy ◽  
Disease Modifying
Sign in / Sign up

Export Citation Format

Share Document